MONOCLONAL ANTIBODIES IS GENE THERAPY BIOWEAPON

2 years ago
1.33K

DARZALEX®(daratumumab) - Important Information
https://www.darzalex.com/iv/about-darzalex/what-is-darzalex?msclkid=066e94a78716167188c5f6fe77887ecc&gclsrc=ds

DARZALEX

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761036s004lbl.pdf

Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COV

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427918/pdf/10930_2021_Article_10019.pdf

Methods for producing recombinant coronavirus

https://patents.justia.com/patent/7279327

Complement-fixing monoclonal antibody to human T cells

https://patentimages.storage.googleapis.com/4e/03/a8/31caf884cc0657/US4658019.pdf

They'll say it's Marburg disease NEXT

https://rumble.com/vn9f59-urgent-message-from-university-hospital-manager-and-academic-kieran-morriss.html

Anti-SARS-CoV-2 Monoclonal Antibodies

https://www.covid19treatmentguidelines.nih.gov/therapies/anti-sars-cov-2-antibody-products/anti-sars-cov-2-monoclonal-antibodies/

Coro*navirus Disease 2019 (COV)
Treatment Guidelines

https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf

Pharmaceutical agent for inducing specific immunity against sars-cov-2 patent WO2021076010A1

https://patentimages.storage.googleapis.com/dc/9e/77/fe36e6bf2e28c0/WO2021002776A1.pdf

Pharmaceutical agent for inducing specific immunity against sars-cov-2

https://pubchem.ncbi.nlm.nih.gov/patent/WO-2021076010-A1

Determination of Regulatory Review Period for Purposes of Patent Extension; DARZALEX

https://www.federalregister.gov/documents/2018/02/20/2018-03342/determination-of-regulatory-review-period-for-purposes-of-patent-extension-darzalex

Daratumumab - National Cancer Institute

https://www.cancer.gov/about-cancer/treatment/drugs/daratumumab

Monoclonal Antibodies - PubMed

https://duckduckgo.com/?q=MONOCLONAL+ANTIBODIES&atb=v314-1&ia=web#:~:text=Monoclonal%20Antibodies%20%2D%20PubMed

FDA Watch: Monoclonal Antibody Treatments for COV

https://www.everydayhealth.com/fda/fda-watch-monoclonal-antibody-treatments-for-covid-19-preventive-flu-medication-and-an-anti-nightmare-device-get-go-ahead/

FDA authorizes REGEN-COV monoclonal antibody therapy for post-exposure prophylaxis (prevention) for COV

https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-regen-cov-monoclonal-antibody-therapy-post-exposure-prophylaxis-prevention-covid-19

Regeneron Pharmaceuticals, Inc.

https://www.fda.gov/media/145610/download

Spikevax and Moderna COV Vaxxine

https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/spikevax-and-moderna-covid-19-vaccine

Comirnaty and Pfizer-BioNTech COV Vaxxine

https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/comirnaty-and-pfizer-biontech-covid-19-vaccine

cd38 (nm_001775) human tagged orf clone lentiviral particle

https://www.origene.com/catalog/cdna-clones/lentiviral-particles/rc203179l4v/cd38-nm_001775-human-tagged-orf-clone-lentiviral-particle

original link by Sovereign Insights

https://www.bitchute.com/video/bvJidCnz7GDa/

Loading 7 comments...